Availability: Άμεσα Διαθέσιμο

Textbook of SARS-CoV-2 and COVID-19, 1st Edition

SKU: 9780323875394
ISBN: 9780323875394
Εκδόσεις:
Διαστάσεις 28 × 22 cm
Μορφή

Εκδόσεις

Ημ. Έκδοσης

Σελίδες

Έκδοση

Συγγραφείς

Κύριος Συγγραφέας

Original price was: 122,00€.Η τρέχουσα τιμή είναι: 109,00€.(Περιλαμβάνεται ΦΠΑ 6%)

Διαθέσιμο - Προπαραγγελία|Διαθεσιμότητα: 11-14 ημέρες default

Υπό την προϋπόθεση ύπαρξης αποθέματος στον εκδότη. Το προϊόν δεν είναι άμεσα διαθέσιμο στο κατάστημα.

Περιγραφή

Written by physicians and scientists with expertise in this evolving area, Textbook of SARS-CoV-2 and COVID-19 provides a coherent, readable, and clinically relevant review of the biology, epidemiology, pathophysiology, immunology, clinical features, current treatment, and prevention strategies for the SARS-CoV-2 virus. Using both a systemic and topic-based approach, it summarizes and clarifies the extensive literature published on SARS-CoV-2 and COVID-19, includes a comprehensive bibliography, and provides answers to clinical questions at the point of care from multiple specialty perspectives.
Key Features
  • Includes dedicated chapters for pulmonary, cardiac, neurological, and oral manifestations of COVID-19.
  • Covers therapeutics and novel therapeutic targets of SARS-CoV-2 and COVID-19.
  • Addresses the diagnostic and management challenges of COVID-19 in the emergency department.
  • Discusses COVID-19 in special populations, including the effect of SARS-CoV-2 infection in pregnant mothers and to the fetus and newborn.
  • Provides a systematic overview and comparison of vaccines that are approved and in development.
  • Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.
Author Information
By Subramani Mani, MBBS (MD), PhD, Independent research consultant; Former Associate Professor, Department of Medicine, University of New Mexico School of Medicine; Former Assistant Professor, Department of Biomedical Informatics, Vanderbilt University, Franklin, Tennessee and Jorn-Hendrik Weitkamp, MD, Associate Professor of Pediatrics, Monroe Carrell Jr. Children’s Hospital, Vanderbilt University Medical Center, Nashville, Tennessee

Περιεχόμενα

  • Cover Image
  • Title Page
  • Copyright
  • Dedication
  • Contributors
  • Acknowledgments
  • Preface
  • Table of Contents
  • Part I The Basics: Epidemiology, Biology, Pathogenesis, Immunology, and Natural History
  • Chapter 1 Epidemiology of SARS-CoV-2 and COVID-19
  • Outline
  • Asia
  • Europe
  • Americas
  • Africa
  • Oceania
  • Risk Factors for COVID-19
  • Conclusion
  • References
  • Chapter 2 SARS-CoV-2: Structure, Pathogenesis, and Diagnosis
  • Outline
  • SARS-CoV-2 and Coronaviruses
  • Structural Proteins
  • Accessory Proteins
  • Nonstructural Proteins
  • Mechanisms of SARS-CoV-2 Pathogenesis
  • Testing for Present and Past Infection
  • Conclusion
  • Acknowledgments
  • References
  • Chapter 3 Immunology of COVID-19
  • Outline
  • Innate Immune Responses
  • Adaptive Immune Responses
  • Immune Dysregulation and Immunopathology
  • The Global Pandemic and Questions for Future Research
  • Conclusion
  • Acknowledgments
  • References
  • Chapter 4 COVID-19: Natural History and Spectrum of Disease
  • Outline
  • Short Comparison of SARS-CoV-2 With SARS-CoV-1 and MERS-CoV
  • Natural History
  • Spectrum of COVID-19
  • Pathogenesis
  • Clinical Characteristics
  • Impact of Comorbidities
  • Radiology and Laboratory Features
  • Treatment, Clinical Course, and Outcomes
  • Drug Pipeline
  • Vaccines
  • Children and COVID-19
  • Post Recovery Symptoms and the Long-Hauler Syndrome
  • Racial Disparities in Susceptibility to SARS-CoV-2
  • Conclusion
  • References
  • Part II The Clinical: Manifestations in Systems and Domains of the Body
  • Chapter 5 Pulmonary Manifestations of COVID-19
  • OUTLINE
  • COVID-19 Manifestations in the Respiratory System
  • Treatment and Management of Salient Pulmonary Manifestations and Complications of COVID-19
  • Management of Respiratory Failure
  • Current Guidelines and Medications Available for Management of COVID-19
  • General Principles of Management of Long-Term Pulmonary Sequelae
  • Case Reports Highlighting the Varied Pulmonary Manifestations of COVID-19
  • CONCLUSION
  • References
  • Chapter 6 COVID-19 and the Cardiovascular System
  • OUTLINE
  • Epidemiology of Cardiac Injury From COVID-19
  • History of Cardiovascular Effects From SARS-CoV-1 and MERS-CoV
  • Pathophysiology and Potential Mechanisms of Cardiovascular Injury From COVID-19
  • Clinical Manifestations and Complications
  • Cardiovascular Comorbidities and COVID-19
  • Management of COVID-19–Related Cardiac Complications
  • Case Reports
  • COVID-19–Induced Cardiac Complications and Long-Term Sequelae
  • Conclusion
  • References
  • Chapter 7 Neurological Manifestations of COVID-19
  • Outline
  • Epidemiology of Neurological Manifestations of COVID-19
  • Historical Background of Neurological Effects of the Coronavirus Family
  • Pathophysiology, Pathogenesis, and Proposed Mechanisms of the SARS-CoV-2 Virus and the Nervous System
  • COVID-19 and the Peripheral Nervous System
  • COVID-19 and the Central Nervous System
  • Long COVID and Neurological Postacute Sequelae of SARS-CoV-2 Infection
  • COVID 19 and Challenges
  • Summary
  • References
  • Chapter 8 Oral Cavity and COVID-19: Clinical Manifestations, Pathology, and Dental Profession
  • Outline
  • The Oral Cavity and Viral Infections
  • SARS-CoV-2 and the Oral Cavity
  • Mechanisms of Oral Manifestations of SARS-CoV-2
  • The Oral Microbiome and COVID-19
  • Salivary Diagnostics, Transmission, and Biomarkers for COVID-19
  • SARS-CoV-2 and the Dental Office
  • Conclusion
  • References
  • Chapter 9 Gastrointestinal Manifestations of COVID-19
  • Outline
  • Prevalence of Gastrointestinal Symptoms
  • Implications of Gastrointestinal Symptoms in COVID-19
  • Mechanism on How SARS-CoV-2 Affects Gut Health
  • Impact of Gastric Acid Reduction on COVID-19 Outcomes
  • Impact of COVID-19 in Inflammatory Bowel Disease
  • Impact of COVID-19 on Liver
  • Impact of COVID-19 on Pancreatic Disorders
  • Association Between Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Use and Gastrointestinal Symptoms in COVID-19
  • Postinfectious Gastrointestinal Symptoms
  • Conclusion
  • References
  • Chapter 10 Kidney Manifestations of COVID-19
  • Outline
  • Acute Kidney Injury Incidence and Mortality Associated With SARS-CoV-2 Infection
  • Could Viral Tropism in Kidney Parenchyma Be Responsible for Acute Kidney Injury?
  • Tubular Injury in COVID-19
  • Glomerular Disease and COVID-19
  • COVID-19–Associated Nephropathy
  • Reports of Other Glomerulonephritis
  • Thrombotic Microangiopathy
  • Proposed Mechanisms
  • Management of COVID-19 Acute Kidney Injury
  • Medication Treatment
  • Renal Replacement Therapy
  • Unique Kidney Populations and COVID-19
  • End-Stage Kidney Disease and COVID-19
  • Transplant and COVID-19
  • Mortality of COVID-19 Infection in Kidney Transplant
  • Impact on Kidney Transplantation and Medication Management
  • Conclusion
  • References
  • Chapter 11 Ophthalmic Manifestations of COVID-19
  • Outline
  • Introduction and Historical Perspectives
  • Role of the Eye in Transmission and Prevention
  • Ocular Manifestations
  • Conclusion
  • References
  • Chapter 12 Psychiatric Manifestations of COVID-19
  • Outline
  • Introduction
  • Delirium
  • Impact of Preexisting Psychiatric Disorders on COVID-19 Outcomes
  • Anxiety, Depression, Mania, and Suicide Risk
  • Posttraumatic Stress Disorder and Trauma-Related Symptoms
  • Psychosis and Catatonia
  • Psychiatric Symptoms Directly Linked to Viral Infection
  • Conclusion
  • References
  • Part III Fetus, Newborn, Infants, Children
  • Chapter 13 Impact of Maternal SARS-CoV-2 Infection on the Fetus and Newborn
  • Outline
  • History of Perinatal Coronavirus Infections
  • Impacts of SARS-CoV-2 Infection on the Pregnant Mother
  • Impact of SARS-CoV-2 Infections on the Fetus and Newborn
  • Conclusion
  • References
  • Chapter 14 COVID-19 in Children and Adolescents
  • Outline
  • Coronavirus Infections in Children and Adolescents
  • Epidemiology of SARS-CoV-2 Infection in Children and Adolescents
  • Clinical Manifestations of SARS-CoV-2 Infection in Infants and Children
  • Treatment of Acute COVID-19 in Children
  • Prevention of SARS-CoV-2 Infection
  • COVID-19 Impact on Well-Being of Children
  • Conclusion
  • References
  • Part IV Special Topics: Emergency Medicine, Therapeutics, Novel Targets, Vaccines
  • Chapter 15 COVID-19: Emergency Medicine Perspectives
  • Outline
  • Introduction
  • Clinical Manifestations
  • Diagnostic Workup and Investigation
  • Management
  • Disposition
  • Special Considerations
  • Conclusion
  • References
  • Chapter 16 Therapeutics for COVID-19
  • Outline
  • Evolution of Therapeutic Approaches
  • Treatments Authorized for Emergency Use
  • Repurposed Drugs and New Molecular Entities in Clinical Development
  • Therapeutic Management: Current Guidelines and Unmet Needs
  • Conclusion
  • References
  • Chapter 17 Novel Therapeutic Targets for SARS-CoV-2 and COVID-19
  • Outline
  • Factors That Affect Therapy for Treatment of COVID-19
  • Emerging Therapeutic Treatments of the Disease
  • Brief Description of Structure and Parts of SARS-CoV-2
  • Therapeutic Targets for the Treatment of COVID-19
  • Overview of Therapies Based on Repurpose Drugs and Corresponding Targets
  • Viral Mutations and Selection of Drug Targets
  • Conclusion
  • References
  • Chapter 18 Vaccine Basics and the Development and Rollout of COVID-19 Vaccines
  • Outline
  • Historical Introduction to Vaccines
  • Vaccines and Vaccinology
  • COVID-19 Vaccine Development
  • COVID-19 Vaccine Rollout
  • Conclusion
  • References
  • Glossary
  • Acronyms
  • Index